Related Experiment Video
Updated: Jul 29, 2025

MitoCeption: Transferring Isolated Human MSC Mitochondria to Glioblastoma Stem Cells
Published on: February 22, 2017
Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases
Mingchu Sun1, Wenhua Jiang1, Nan Mu2
1Institute of Medical Research, Northwestern Polytechnical University, Xi'an, 710072, Shaanxi, P.R. China.
Abstract:
Cardiovascular disease (CVD) is the leading cause of noncommunicable disease-related death worldwide, and effective therapeutic strategies against CVD are urgently needed. Mitochondria dysfunction involves in the onset and development of CVD. Nowadays, mitochondrial transplantation, an alternative treatment aimed at increasing mitochondrial number and improving mitochondrial function, has been emerged with great therapeutic potential. Substantial evidence indicates that mitochondrial transplantation improves cardiac function and outcomes in patients with CVD. Therefore, mitochondrial transplantation has profound implications in the prevention and treatment of CVD. Here, we review the mitochondrial abnormalities that occur in CVD and summarize the therapeutic strategies of mitochondrial transplantation for CVD.
Insights
Mitochondrial dysfunction contributes to cardiovascular disease (CVD). Mitochondrial transplantation shows promise for improving cardiac function and treating CVD by enhancing mitochondrial health.
Area of Science:
- Cardiovascular Medicine
- Mitochondrial Biology
- Regenerative Medicine
Background:
- Cardiovascular disease (CVD) is a major global cause of death.
- Mitochondrial dysfunction is implicated in the development and progression of CVD.
- Current CVD treatments require novel therapeutic strategies.
Purpose of the Study:
- To review mitochondrial abnormalities in CVD.
- To summarize the therapeutic potential of mitochondrial transplantation for CVD.
- To highlight implications for CVD prevention and treatment.
Main Methods:
- Literature review of studies on mitochondrial abnormalities in CVD.
- Analysis of research on mitochondrial transplantation efficacy.
- Synthesis of evidence on mitochondrial transplantation for cardiac outcomes.
Main Results:
- Mitochondrial dysfunction is a key factor in CVD.
- Mitochondrial transplantation can improve cardiac function.
- Evidence supports the therapeutic potential of mitochondrial transplantation in CVD.
Conclusions:
- Mitochondrial transplantation offers a promising therapeutic strategy for CVD.
- Enhancing mitochondrial number and function is crucial for CVD treatment.
- Further research into mitochondrial transplantation for CVD is warranted.
More Related Videos
08:30A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
Published on: February 14, 2022
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014